# Safety and Feasibility of Metformin for Sepsis Induced AKI

> **NCT05900284** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Hernando Gomez** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis
- Septic Shock
- Acute Kidney Injury
- Metformin

## Interventions

- **DRUG:** Metformin low dose
- **DRUG:** Metformin high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05900284
- **Lead sponsor:** Hernando Gomez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-08
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05900284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05900284, "Safety and Feasibility of Metformin for Sepsis Induced AKI". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05900284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*